Investigation of PKCβ, specifically, has revealed that both splice variants (PKCβI and PKCβII) are upregulated in breast tumor versus matched normal patient tissue (20), with cytoplasmic PKCβII associating with Ki-67 expression and HER2 positivity (21). The gene discussed is PRKCB; the disease is breast neoplasm.